AKYA Akoya Biosciences Inc

Price (delayed)

$4.69

Market cap

$230.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.43

Enterprise value

$232.35M

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive ...

Highlights
The gross profit has increased by 30% year-on-year and by 9% since the previous quarter
The revenue has increased by 29% YoY and by 6% QoQ
The debt has grown by 14% from the previous quarter and by 13% YoY
The equity has declined by 13% since the previous quarter and by 8% year-on-year

Key stats

What are the main financial stats of AKYA
Market
Shares outstanding
49.14M
Market cap
$230.47M
Enterprise value
$232.35M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.28
Price to sales (P/S)
2.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.4
Earnings
Revenue
$96.63M
EBIT
-$54.52M
EBITDA
-$45.63M
Free cash flow
-$54.55M
Per share
EPS
-$1.43
Free cash flow per share
-$1.23
Book value per share
$1.1
Revenue per share
$2.17
TBVPS
$3.26
Balance sheet
Total assets
$180.37M
Total liabilities
$126.6M
Debt
$85.71M
Equity
$53.77M
Working capital
$86.45M
Liquidity
Debt to equity
1.59
Current ratio
3.45
Quick ratio
2.85
Net debt/EBITDA
-0.04
Margins
EBITDA margin
-47.2%
Gross margin
58.3%
Net margin
-65.5%
Operating margin
-58%
Efficiency
Return on assets
-36.1%
Return on equity
-110.2%
Return on invested capital
-53.6%
Return on capital employed
-37.6%
Return on sales
-56.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AKYA stock price

How has the Akoya Biosciences stock price performed over time
Intraday
-0.85%
1 week
-6.01%
1 month
-17.14%
1 year
-42.24%
YTD
-3.89%
QTD
-3.89%

Financial performance

How have Akoya Biosciences's revenue and profit performed over time
Revenue
$96.63M
Gross profit
$56.31M
Operating income
-$56.03M
Net income
-$63.32M
Gross margin
58.3%
Net margin
-65.5%
Akoya Biosciences's operating margin has increased by 34% YoY and by 18% from the previous quarter
The net margin has grown by 31% YoY and by 16% from the previous quarter
The gross profit has increased by 30% year-on-year and by 9% since the previous quarter
The revenue has increased by 29% YoY and by 6% QoQ

Growth

What is Akoya Biosciences's growth rate over time

Valuation

What is Akoya Biosciences stock price valuation
P/E
N/A
P/B
4.28
P/S
2.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.4
Akoya Biosciences's EPS has increased by 24% YoY and by 19% from the previous quarter
The equity has declined by 13% since the previous quarter and by 8% year-on-year
AKYA's price to book (P/B) is 13% lower than its last 4 quarters average of 4.9
The price to sales (P/S) is 30% lower than the last 4 quarters average of 3.1
The revenue has increased by 29% YoY and by 6% QoQ

Efficiency

How efficient is Akoya Biosciences business performance
Akoya Biosciences's ROS has increased by 36% YoY and by 18% from the previous quarter
The ROE has contracted by 29% YoY but it has grown by 9% from the previous quarter
The return on invested capital is up by 17% year-on-year and by 15% since the previous quarter
Akoya Biosciences's return on assets has increased by 12% QoQ and by 7% YoY

Dividends

What is AKYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AKYA.

Financial health

How did Akoya Biosciences financials performed over time
AKYA's total assets is 42% greater than its total liabilities
The company's quick ratio rose by 16% YoY and by 7% QoQ
Akoya Biosciences's current ratio has increased by 14% YoY and by 4.9% QoQ
The debt is 59% more than the equity
Akoya Biosciences's debt to equity has increased by 31% from the previous quarter and by 23% YoY
The debt has grown by 14% from the previous quarter and by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.